KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 9 analysts with an average price target of $204.52. This is a potential upside of $35.4 (20.93%) from yesterday's end of day stock price of $169.12.

Krystal Biotech's activity chart (see below) currently has 60 price targets and 76 ratings on display. The stock rating distribution of KRYS is 91.89% BUY and 8.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.92% with an average time for these price targets to be met of 287.33 days.

Highest price target for KRYS is $221, Lowest price target is $215, average price target is $187.67.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 28-Jun-2018.

Currently out of the existing stock ratings of KRYS, 34 are a BUY (91.89%), 3 are a HOLD (8.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$221

$52.43 (31.10%)

$221

1 months 27 days ago
(28-Feb-2025)

24/31 (77.42%)

$41.35 (23.02%)

210

Buy

$218

$49.43 (29.32%)

$212

2 months 4 days ago
(20-Feb-2025)

7/10 (70%)

$61.31 (39.13%)

409

Buy

$215

$46.43 (27.54%)

2 months 4 days ago
(20-Feb-2025)

4/5 (80%)

$58.31 (37.21%)

139

Hold

$215

$46.43 (27.54%)

$206

2 months 4 days ago
(20-Feb-2025)

1/4 (25%)

$58.31 (37.21%)

135

Buy

$220

$51.43 (30.51%)

$145

7 months 13 days ago
(11-Sep-2024)

2/3 (66.67%)

$21.21 (10.67%)

156

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 287.33 days on average for the stock forecasts to be realized with a an average price target met ratio 84.92

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 3 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Joseph Pantginis with highest potential upside - $52.43

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$66

Krystal Biotech in the News

Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Kiniksa Pharmaceuticals, Ltd. (KNSA) been one of those stocks this year? Let’s take a closer look at the stock’s year-to-date performance to find out. Kiniksa Pharmaceuticals, Ltd. is one of 1003 individual stocks...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?